FoodFeb 26, 2025
Global Commodities AAHU BARAH brand SOFT PLUM recall — FDA F-0568-2025
Product contains undeclared sulfites (4.66 mg/serving).
Class IIFDA: OngoingGlobal Commodities Inc.
Monthly breakdown
2025 recalls by month
Select a month to review the recall records reported during that period.
December 2025389 records · 4 categoriesNovember 2025326 records · 4 categoriesOctober 2025455 records · 4 categoriesSeptember 2025285 records · 4 categoriesAugust 2025239 records · 4 categoriesJuly 2025370 records · 4 categoriesJune 2025342 records · 4 categoriesMay 2025258 records · 4 categoriesApril 2025302 records · 4 categoriesMarch 2025259 records · 4 categoriesFebruary 2025260 records · 4 categoriesJanuary 2025354 records · 4 categories
2025 recalls — page 138
Records are ordered by the best available source date.
DrugFeb 26, 2025
Atomoxetine Capsules, USP, 40 mg, 30 capsule bottles recall — FDA D-0241-2025
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Class IIFDA: OngoingGlenmark Pharmaceuticals Inc., USA
DrugFeb 26, 2025
Atomoxetine Capsules, USP, 10 mg, 30 capsule bottles recall — FDA D-0238-2025
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Class IIFDA: OngoingGlenmark Pharmaceuticals Inc., USA
DrugFeb 26, 2025
Lorazepam Tablets, USP, 2mg, Unit Dose, 100 tablets per carton (10 x 10 blister packs) recall — FDA D-0228-2025
Failed impurities/degradation specifications and Sub-potent Drug: Out-of-specification results were obtained during routine stability testing for Assay and Impurities.
Class IIFDA: OngoingThe Harvard Drug Group LLC dba Major Pharmaceuticals…
DrugFeb 26, 2025
Atomoxetine Capsules, USP, 60 mg, 30 capsule bottles recall — FDA D-0242-2025
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Class IIFDA: OngoingGlenmark Pharmaceuticals Inc., USA
DrugFeb 26, 2025
Lorazepam Tablets, USP, 1mg, Unit Dose, 100 tablets per carton (10 x 10 blister packs) recall — FDA D-0227-2025
Failed impurities/degradation specifications and Sub-potent Drug: Out-of-specification results were obtained during routine stability testing for Assay and Impurities.
Class IIFDA: OngoingThe Harvard Drug Group LLC dba Major Pharmaceuticals…
DrugFeb 26, 2025
Silodosin Capsules, 8mg, 90-count bottle recall — FDA D-0229-2025
Subpotent Drug: Out of Specification (OOS) result for De hydro Impurity (0.654%) for 18 M Stability sample and low assay 94.9% (specification of NLT 95.0% NMT 105%)
Class IIFDA: OngoingAvKARE
DrugFeb 26, 2025
Atomoxetine Capsules, USP, 80 mg, 30 capsule bottles recall — FDA D-0243-2025
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Class IIFDA: OngoingGlenmark Pharmaceuticals Inc., USA
DrugFeb 26, 2025
Fentanyl Transdermal System CII, 25mcg/h recall — FDA D-0245-2025
Defective delivery system - patches could be multi-stacked, adhered one on top of the other, in a single product pouch.
Class IFDA: OngoingAlvogen, Inc
DrugFeb 26, 2025
Atomoxetine Capsules, USP, 25 mg, 30 capsule bottles recall — FDA D-0240-2025
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Class IIFDA: OngoingGlenmark Pharmaceuticals Inc., USA
DrugFeb 26, 2025
Atomoxetine Capsules, USP, 100 mg, 30 capsule bottles recall — FDA D-0244-2025
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Class IIFDA: OngoingGlenmark Pharmaceuticals Inc., USA
DrugFeb 26, 2025
Atomoxetine Capsules, USP, 18 mg, 30 capsule bottles recall — FDA D-0239-2025
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Class IIFDA: OngoingGlenmark Pharmaceuticals Inc., USA
DrugFeb 26, 2025
Lorazepam Tablets, USP, 0.5mg, Unit Dose, 100 tablets per carton (10 x 10 blister packs) recall — FDA D-0226-2025
Failed impurities/degradation specifications and Sub-potent Drug: Out-of-specification results were obtained during routine stability testing for Assay and Impurities.
Class IIFDA: OngoingThe Harvard Drug Group LLC dba Major Pharmaceuticals…
VehicleFeb 21, 2025
X3 30 xDrive cables recall — NHTSA campaign 25V109000
BMW of North America, LLC (BMW) is recalling certain 2025 X3 30 xDrive vehicles. The connection between the positive battery cable and the starter-generator may have been improperly…
cablesBMW of North America, LLC
VehicleFeb 20, 2025
BMW lock recall — NHTSA campaign 25V106000
BMW of North America, LLC (BMW) is recalling certain 2022-2024 X3 sDrive30i and X3 xDrive30i vehicles. The second-row seat side door locking modules may not function properly and allow the…
lockBMW of North America, LLC
Medical DeviceFeb 19, 2025
CareFusion 303 BD Pyxis MedStation Auxiliary ES REF: 324 recall — FDA Z-1123-2025
Retroactive-Due to increase in complaints, their is a potential for drawer and/or door failures of the medication cabinet which could result in delay in accessing medications.
Class IIFDA: OngoingCareFusion 303, Inc.
Medical DeviceFeb 19, 2025
Exactech Alteon XLE Item Number / Product Description: 140-22-70 NV EHXL NTL LNR G00 22MM recall — FDA Z-1167-2025
Due to the lack of the Ethylene Vinyl Alcohol (EVOH) barrier layer.
Class IIFDA: OngoingExactech, Inc.
Medical DeviceFeb 19, 2025
Sertera Biopsy Device recall — FDA Z-1170-2025
Devices presented a condition in which the inner needle separated from the hub and produced a longer throw of the inner needle or dislodgement.
Class IIFDA: OngoingHologic, Inc.
Medical DeviceFeb 19, 2025
Cardinal Health Presource Kits: 1) OPHTHALMOLOGY ENDO DCR XTRS PK recall — FDA Z-1136-2025
Potential for endotoxin contamination in non-sterile surgical strips and patties in Presource Kits.
Class IIFDA: OngoingCardinal Health 200, LLC
Medical DeviceFeb 19, 2025
CareFusion 303 BD Pyxis MedStation ES (Med ES Main) REF: 323 recall — FDA Z-1122-2025
Retroactive-Due to increase in complaints, their is a potential for drawer and/or door failures of the medication cabinet which could result in delay in accessing medications.
Class IIFDA: OngoingCareFusion 303, Inc.
Medical DeviceFeb 19, 2025
Cardinal Health Presource Kits: 1) KIT,NEURO LAMI,MD ANDERSON recall — FDA Z-1127-2025
Potential for endotoxin contamination in non-sterile surgical strips and patties in Presource Kits.
Class IIFDA: OngoingCardinal Health 200, LLC
Medical DeviceFeb 19, 2025
CareFusion 303 BD Pyxis MedStation Auxiliary 4000 REF: 306 recall — FDA Z-1124-2025
Retroactive-Due to increase in complaints, their is a potential for drawer and/or door failures of the medication cabinet which could result in delay in accessing medications.
Class IIFDA: OngoingCareFusion 303, Inc.
Medical DeviceFeb 19, 2025
Cardinal Health Presource Kits: 1) CHI STD NEURO CRANI OPT 1 recall — FDA Z-1134-2025
Potential for endotoxin contamination in non-sterile surgical strips and patties in Presource Kits.
Class IIFDA: OngoingCardinal Health 200, LLC
Medical DeviceFeb 19, 2025
CareFusion 303 (1) BD Pyxis MedStation ES, Catalog No. 323 recall — FDA Z-1120-2025
Labeling is insufficient regarding delays in access to medication. The firm is strengthening the label as an additional risk mitigation.
Class IIFDA: OngoingCareFusion 303, Inc.
About the 2025 recall archive
This archive groups records by their reported or recall date. It does not imply that every recall was initiated, announced and resolved during the same calendar year. Open the individual record for the exact dates and source details supplied by FDA or NHTSA.